Pall Corporation and RoosterBio, Inc. Announce Collaboration Agreement to Market Mesenchymal Stem/Stromal Cells and Bioreactor Expansion Systems
October 5, 2016: New collaboration to deliver complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs), to accelerate product development, reduce clinical translation timelines and streamline the commercialization pathway for stem cell-based therapies
Pall Corporation and Artesyn Biosolutions Announce Collaboration Agreement to Industrialize Single-Use Technology
April 15, 2018: Patrnership to bring together Artesyn Biosolutions' valves and fluid handling technologies with Pall's Allegro solutions including bioreactors, range of downstream automated equipment and mixers to enable customers to implement efficient single-use manufacturing lines
Pall Life Sciences Commits to Innovative Technology Advances, Building Key Partnerships to Advance the Drug Production Industry in 2018
December 13, 2017: Several recent and upcoming high-profile partnership announcements announced to help advance the drug production industry through key technology innovations
New Stax™ mAx Clarification Platform Delivers Robust, Accelerated Performance Across Multiple mAb Processes
November 21, 2017: Introducing a new and robust solution for the economic clarification of mAb (monoclonal antibody) cell cultures without the need for centrifugation or process additives
Pall Medical takes the lead in patient care focus with hospital water filter US FDA 510K clearance for QPoint point-of-use filter.
Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.
2M Nanyang Polytechnic Center of Excellence Features Pall Biotech Equipment, Opens as Singapore’s First-Ever Integrated Biopharmaceutical Training Facility
Feb 21, 2018: New centre to benefit students and the wider Biotech industry through direct access to the latest technologies including chromatography column packing and filter integrity testing apparatus
University College London in Strategic Alliance with Pall Biotech to Open Fit-for-Purpose Biotech Centre of Excellence for Research, Development and Training
October 2, 2018: New centre will work to enhance drug production and empower the future workforce, reinforcing Pall's commitment to continuously improve bioprocesses through strategic partnerships
December 18, 2018: New centre to give Pall customers options ranging from batch to single use and continuous bioprocessing solutions, and to provide technology solutions that meet current needs, while offering some of the most progressive technological solutions for the future
Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies
November 26, 2018: Cobra and Pall to make commercialisation of gene therapies safer, faster, and cheaper than ever before, help increase patient access to gene therapy and further establish best practices in manufacturing
Pall Corporation and Broadley-James Cooperate to Deliver Next Generation Single-Use Sensor Technologies to the Life Science Market
March 11, 2019: Pall to integrate and distribute Broadley-James’ advanced single-use probe and flow cell pH sensors; sensor will be integrated into Pall single-use technologies
Pall Corporation Chosen as Single-Source Supplier by Servier for Purpose Built End-to-End Biomanufacturing Facility in Gidy, France
July 16, 2019: Servier chooses Pall as exclusive technology and services provider for planned Bio-S biomanufacturing facility in France
July 26, 2017: Announcing a new bioreactor control system - the first in Pall's next generation of unifying technologies for a seamless, fully controlled, and value-based user experience
New Cadence™ Inline Diafiltration Modules Debuted at Pall Life Sciences Leadership Forum at Westborough, MA Center of Excellence
November 14, 2017: New modules enable fully continuous processes in UF/DF processing steps, available in a range of size formats for use in one or more locations of a continuous mAb downstream purification process
Brammer Bio Expands Cell and Gene Therapy Capacity in Florida and Massachusetts, Partnering with Pall Life Sciences for Suspension and Adherent Platform Technologies
September 25, 2017: Brammer Bio utilizes Pall's critical process solutions and process support, to help focus on building on more than 100 executed projects and 150 clinical cell and gene therapy lots in Florida, including many first-in-human trials
Pall Biotech Expands Hoegaarden, Belgium Facility, Designates it as Strategic Hub for Research and Development, Manufacturing and Customer Support
February 27, 2018: New offices, labs and manufacturing space for development and optimization of customer processes
Pall Corporation and Celltheon Form Strategic Partnership for Biotherapeutics Development and Manufacturing with Celltheon SMART™ Expression Platform
September 3, 2018: Celltheon and Pall to provide an integrated, cost-effective, time efficient end-to-end solution for research and bioproduction to expedite drug development and provide solutions for unmet needs in bioprocessing
June 1, 2021: Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform.
Pall has been working with healthcare professionals to design & produce filtration devices for infection prevention and cost containment. Read more.